SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-412883
Filing Date
2014-11-14
Accepted
2014-11-14 14:15:23
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d809348d10q.htm 10-Q 669010
2 EX-31.1 d809348dex311.htm EX-31.1 6456
3 EX-31.2 d809348dex312.htm EX-31.2 6462
4 EX-32.1 d809348dex321.htm EX-32.1 4821
  Complete submission text file 0001193125-14-412883.txt   5178353

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mbvx-20140930.xml EX-101.INS 597770
6 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20140930.xsd EX-101.SCH 51511
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20140930_cal.xml EX-101.CAL 46737
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20140930_def.xml EX-101.DEF 217838
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20140930_lab.xml EX-101.LAB 407973
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20140930_pre.xml EX-101.PRE 299297
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31265 | Film No.: 141222858
SIC: 2834 Pharmaceutical Preparations